Purdue Frederick Company Inc. pleaded guilty to charges of misbranding Purdue's addictive and highly abusable drug OxyContin. It agreed to pay a total of 600 million to the federal government, state governments and private claimants to settle civil and criminal allegations. Purdue executives were personally required to pay an additional 34 million.